These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21981743)

  • 1. Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions.
    Hornung T; Ko A; Tüting T; Bieber T; Wenzel J
    Clin Exp Dermatol; 2012 Mar; 37(2):139-42. PubMed ID: 21981743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.
    Hasija R; Pistorio A; Ravelli A; Demirkaya E; Khubchandani R; Guseinova D; Malattia C; Canhao H; Harel L; Foell D; Wouters C; De Cunto C; Huemer C; Kimura Y; Mangge H; Minetti C; Nordal EB; Philippet P; Garozzo R; Martini A; Ruperto N;
    Arthritis Rheum; 2011 Oct; 63(10):3142-52. PubMed ID: 21647864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
    Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
    Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
    Feki NB; Khanfir MS; Ghorbel IB; Said F; Houman MH
    Pan Afr Med J; 2016; 23():149. PubMed ID: 27279974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in dermatomyositis rash associated with the use of antiestrogen medication.
    Sereda D; Werth VP
    Arch Dermatol; 2006 Jan; 142(1):70-2. PubMed ID: 16415389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy.
    Tsuji G; Maekawa S; Saigo K; Nobuhara Y; Nakamura T; Kawano S; Koshiba M; Asahara S; Chinzei T; Kumagai S
    Am J Hematol; 2003 Nov; 74(3):175-8. PubMed ID: 14587044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
    Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
    Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC; Werth VP
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin.
    Sigmundsdottir H; Johnston A; Gudjonsson JE; Bjarnason B; Valdimarsson H
    Exp Dermatol; 2004 Jul; 13(7):426-34. PubMed ID: 15217363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyopathic dermatomyositis with plantar keratoderma responding to methotrexate therapy.
    Morrell TJ; Mortensen WS; Langley S
    Cutis; 2017 Aug; 100(2):E20-E24. PubMed ID: 28961302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
    Kasteler JS; Callen JP
    J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous blood flow in dermatomyositis and its association with disease severity.
    Dawn A; Thevarajah S; Cayce KA; Carroll CL; Duque ML; Chan YH; Jorizzo JL; Yosipovitch G
    Skin Res Technol; 2007 Aug; 13(3):285-92. PubMed ID: 17610650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.